Previous close | 1.1600 |
Open | 1.1600 |
Bid | 0.4000 |
Ask | 5.0000 |
Strike | 35.00 |
Expiry date | 2026-01-16 |
Day's range | 1.1600 - 1.1600 |
Contract range | N/A |
Volume | |
Open interest | 73 |
Catalent's (CTLT) new tie-up to support the development and commercial manufacturing of safe, high-quality AAV gene therapies to provide life-saving treatments to cancer patients.
Catalent (CTLT) reports a solid revenue uptick in third-quarter fiscal 2024 despite lower revenues in Biologics segments.
Insightful Analysis of Catalent Inc's Strengths, Weaknesses, Opportunities, and Threats